Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 123   

Articles published

4502 4,482.00 +58.50 (1.32%)
price chart
BioMotiv and Takeda Pharmaceutical Company Enter into Strategic Partnership
CLEVELAND & OSAKA, Japan, Sep 25, 2014 (BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (�Takeda�) and BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development, jointly ...
Related articles »  
Traders Watch List - Ocean Rig UDW Inc (NASDAQ:ORIG), Takeda ...
The company has strategic partnership with BioMotiv, LLC. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.
Takeda Pharmaceutical Co Ltd (ADR)(OTCMKTS:TKPYY) and Sucampo ...
It has very good potential, and that's the main reason Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) and Takeda Pharmaceutical Co Ltd (ADR)(OTCMKTS:TKPYY) are trying their best to educate local people about this drug in the best way possible.
Related articles »  
Sucampo Pharmaceuticals Inc.: Takeda and Sucampo Enter Into Global ...
BETHESDA, Md., October 21, 2014 and OSAKA, Japan, October 22, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, and Takeda Pharmaceutical Company Limited (Takeda) ...
Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R ...  PipelineReview.com (press release)
Related articles »  
Plaintiffs: Takeda's Claim It Found Evidence a 'Whitewash'
Doherty ruled that Takeda Pharmaceutical Company Ltd., the Japanese parent of companies based in the United States and Europe, acted in bad faith in its destruction of documents and violated Federal Rule of Civil Procedure 37.
Seattle Genetics, Takeda's cancer drug meets main goal in trial
(Reuters) - Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer.
Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA ...  MarketWatch
Related articles »  
Takeda, Orexigen Therapeutics (OREX) Announces Availability of CONTRAVE
Takeda Pharmaceutical Company Limited, its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. and Orexigen� Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that Contrave extended-release tablets are now available to patients by ...
Sucampo Pharma (SCMP), Takeda Enter Settlement, Licensing Arrangement ...
Sucampo Pharma (Nasdaq: SCMP) announced that Sucampo, R-Tech Ueno, Ltd. (RTU), Takeda Pharmaceutical Company Limited (Takeda) and certain affiliates of Takeda have entered into a settlement and license agreement with Anchen Pharmaceuticals, ...
Sucampo Announces Settlement Agreement That Resolves Patent Litigation in ...  NASDAQ
R-Tech Ueno: Settlement Agreement That Resolves Patent Litigation in US ...  Business Wire (press release)
Related articles »  
BUZZ-Orexigen Therapeutics Inc: Diet drug launched
Company and partner Takeda Pharmaceutical Co Ltd said on Monday they launched their recently approved diet pill, Contrave, in the United States.
MacroGenics and Takeda Enter Second Strategic Alliance to Develop Multiple ...
29, 2014 (GLOBE NEWSWIRE) -- ROCKVILLE, Maryland and OSAKA, Japan - September 29, 2014 - MacroGenics, Inc. (NASDAQ: MGNX) and Takeda Pharmaceutical Company Limited jointly announced today that they have entered into a collaboration ...
Related articles »